Global Bilirubin Blood Test Market

Bilirubin Blood Test Comprehensive Study by Type (Transcutaneous, Bench-top), Application (Disease Diagnose, Blood Routine Analysis, Disease Prevention, Others), End Use (Hospital, Clinic, Healthcare Institutes, Other) Players and Region - Global Market Outlook to 2030

Bilirubin Blood Test Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Bilirubin Blood Test
The bilirubin blood test measures the levels of bilirubin in the blood. It is used to check the health of an individual’s liver Bilirubin is a yellowish substance made during the body's normal process of breaking down red blood cells. To identify symptoms such as jaundice, dark urine, or stomach pain bilirubin blood test is used. It is also used to find out the blockage in the structures that carry bile from an individual’s liver.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR4.9%


The companies are involved in the testing and development of new bilirubin blood testing equipment and techniques. They form joint ventures, mergers, and acquisitions to launch new devices. Their primary goal is to provide devices that are cost-effective, easy to use, and produce tangible results.The Players having a strong hold in the market are Philips, Drägerwerk AG & Co. KGaA, and Konica Minolta. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Bilirubin Blood Test market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Philips (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Konica Minolta (Japan), Natus Medical Incorporated (United States), APEL Co.,Ltd. (Japan), AMETEK, Inc. (United States), Mennen Medical Ltd. (United States), Advanced Instruments (United States), GINEVRI srl (Italy) and AVI Healthcare Pvt Ltd (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Beijing M&B (China), Kejian Hi-tech (China) and Micro Lab (India).

Segmentation Overview
AMA Research has segmented the market of Global Bilirubin Blood Test market by Type (Transcutaneous and Bench-top), Application (Disease Diagnose, Blood Routine Analysis, Disease Prevention and Others) and Region.



On the basis of geography, the market of Bilirubin Blood Test has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Hospital will boost the Bilirubin Blood Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Serum Bilirubin has an Important Role in Multiple Clinical Applications

Market Growth Drivers:
Bilirubin is found in the newborn babes is driving the global bilirubin blood test market., The test is also normally used to help diagnose newborn jaundice., Many healthy babies get jaundice because their livers aren't mature enough to get rid of enough bilirubin. and Newborn jaundice is usually harmless and clears up within a few weeks. But in some cases, high bilirubin levels can lead to brain damage, so infants are often tested as a precaution.

Challenges:
Transdermal bilirubin meters are composed of components such as patch, scanner, battery, receiver and transmitter, and the integration of advanced technologies further increases the cost of the system.

Restraints:
High Cost Involved in the Liver Function Tests like Bilirubin Blood Test and Difficulties in Determining the Type of Disease and Possible Causes

Opportunities:
Raising Awareness about the Liver Diseases will Boost the Bilirubin Blood Test Market and Technological Advancements in Bilirubin Blood Test Equipments and Diagnosis

Market Leaders and their expansionary development strategies
In December 2023, The Indian Institute of Technology Kanpur (IIT-K) has signed a Memorandum of Understanding (MoU) with Sensa Core Medical Instrumentation for mass manufacturing and sales of a novel point-of-care technology developed at the institute for rapid analysis of bilirubin in human blood/serum along with its three variants.
In December 2023, A new non-invasive way to test jaundice in babies is being introduced today at Walsall Healthcare NHS Trust. Jaundice is one of the most common conditions that can affect newborn babies and is usually harmless. It causes yellowing of the skin and the whites of the eyes.
The Food and Drug Administration said that the manufacturers Endo Pharmaceuticals Inc., and Novartis Consumer Health Inc., had revised the “hepatic effects” section of the diclofenac topical gel label to include new warnings and precautions about the potential for elevated liver function tests (LFTs) during treatment. The revised label both recommend that clinicians should periodically measure transaminase levels in patients taking diclofenac long-term. While the optimum schedule for checking transaminase levels is unknown, clinical trial data and postmarketing experience indicate that levels should be monitored within 4–8 weeks after initiating treatment, according to the FDA notice.

Key Target Audience
Bilirubin Blood Test Providers, Bilirubinometer Manufacturers, Healthcare Research Center, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Other

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Transcutaneous
  • Bench-top
By Application
  • Disease Diagnose
  • Blood Routine Analysis
  • Disease Prevention
  • Others
By End Use
  • Hospital
  • Clinic
  • Healthcare Institutes
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Bilirubin is found in the newborn babes is driving the global bilirubin blood test market.
      • 3.2.2. The test is also normally used to help diagnose newborn jaundice.
      • 3.2.3. Many healthy babies get jaundice because their livers aren't mature enough to get rid of enough bilirubin.
      • 3.2.4. Newborn jaundice is usually harmless and clears up within a few weeks. But in some cases, high bilirubin levels can lead to brain damage, so infants are often tested as a precaution.
    • 3.3. Market Challenges
      • 3.3.1. Transdermal bilirubin meters are composed of components such as patch, scanner, battery, receiver and transmitter, and the integration of advanced technologies further increases the cost of the system.
    • 3.4. Market Trends
      • 3.4.1. Serum Bilirubin has an Important Role in Multiple Clinical Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bilirubin Blood Test, by Type, Application, End Use and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Bilirubin Blood Test (Value)
      • 5.2.1. Global Bilirubin Blood Test by: Type (Value)
        • 5.2.1.1. Transcutaneous
        • 5.2.1.2. Bench-top
      • 5.2.2. Global Bilirubin Blood Test by: Application (Value)
        • 5.2.2.1. Disease Diagnose
        • 5.2.2.2. Blood Routine Analysis
        • 5.2.2.3. Disease Prevention
        • 5.2.2.4. Others
      • 5.2.3. Global Bilirubin Blood Test by: End Use (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Clinic
        • 5.2.3.3. Healthcare Institutes
        • 5.2.3.4. Other
      • 5.2.4. Global Bilirubin Blood Test Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Bilirubin Blood Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Philips (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Drägerwerk AG & Co. KGaA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Konica Minolta (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Natus Medical Incorporated (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. APEL Co.,Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AMETEK, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mennen Medical Ltd. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Advanced Instruments (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GINEVRI srl (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AVI Healthcare Pvt Ltd (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bilirubin Blood Test Sale, by Type, Application, End Use and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Bilirubin Blood Test (Value)
      • 7.2.1. Global Bilirubin Blood Test by: Type (Value)
        • 7.2.1.1. Transcutaneous
        • 7.2.1.2. Bench-top
      • 7.2.2. Global Bilirubin Blood Test by: Application (Value)
        • 7.2.2.1. Disease Diagnose
        • 7.2.2.2. Blood Routine Analysis
        • 7.2.2.3. Disease Prevention
        • 7.2.2.4. Others
      • 7.2.3. Global Bilirubin Blood Test by: End Use (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Clinic
        • 7.2.3.3. Healthcare Institutes
        • 7.2.3.4. Other
      • 7.2.4. Global Bilirubin Blood Test Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bilirubin Blood Test: by Type(USD Million)
  • Table 2. Bilirubin Blood Test Transcutaneous , by Region USD Million (2018-2023)
  • Table 3. Bilirubin Blood Test Bench-top , by Region USD Million (2018-2023)
  • Table 4. Bilirubin Blood Test: by Application(USD Million)
  • Table 5. Bilirubin Blood Test Disease Diagnose , by Region USD Million (2018-2023)
  • Table 6. Bilirubin Blood Test Blood Routine Analysis , by Region USD Million (2018-2023)
  • Table 7. Bilirubin Blood Test Disease Prevention , by Region USD Million (2018-2023)
  • Table 8. Bilirubin Blood Test Others , by Region USD Million (2018-2023)
  • Table 9. Bilirubin Blood Test: by End Use(USD Million)
  • Table 10. Bilirubin Blood Test Hospital , by Region USD Million (2018-2023)
  • Table 11. Bilirubin Blood Test Clinic , by Region USD Million (2018-2023)
  • Table 12. Bilirubin Blood Test Healthcare Institutes , by Region USD Million (2018-2023)
  • Table 13. Bilirubin Blood Test Other , by Region USD Million (2018-2023)
  • Table 14. South America Bilirubin Blood Test, by Country USD Million (2018-2023)
  • Table 15. South America Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 16. South America Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 17. South America Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 18. Brazil Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 19. Brazil Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 20. Brazil Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 21. Argentina Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 22. Argentina Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 23. Argentina Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 24. Rest of South America Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 27. Asia Pacific Bilirubin Blood Test, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 31. China Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 32. China Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 33. China Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 34. Japan Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 35. Japan Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 36. Japan Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 37. India Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 38. India Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 39. India Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 40. South Korea Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 41. South Korea Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 42. South Korea Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 43. Taiwan Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 44. Taiwan Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 45. Taiwan Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 46. Australia Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 47. Australia Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 48. Australia Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 52. Europe Bilirubin Blood Test, by Country USD Million (2018-2023)
  • Table 53. Europe Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 54. Europe Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 55. Europe Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 56. Germany Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 57. Germany Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 58. Germany Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 59. France Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 60. France Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 61. France Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 62. Italy Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 63. Italy Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 64. Italy Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 65. United Kingdom Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 68. Netherlands Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 69. Netherlands Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 70. Netherlands Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 71. Rest of Europe Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 74. MEA Bilirubin Blood Test, by Country USD Million (2018-2023)
  • Table 75. MEA Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 76. MEA Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 77. MEA Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 78. Middle East Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 79. Middle East Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 80. Middle East Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 81. Africa Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 82. Africa Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 83. Africa Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 84. North America Bilirubin Blood Test, by Country USD Million (2018-2023)
  • Table 85. North America Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 86. North America Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 87. North America Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 88. United States Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 89. United States Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 90. United States Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 91. Canada Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 92. Canada Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 93. Canada Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 94. Mexico Bilirubin Blood Test, by Type USD Million (2018-2023)
  • Table 95. Mexico Bilirubin Blood Test, by Application USD Million (2018-2023)
  • Table 96. Mexico Bilirubin Blood Test, by End Use USD Million (2018-2023)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Bilirubin Blood Test: by Type(USD Million)
  • Table 108. Bilirubin Blood Test Transcutaneous , by Region USD Million (2025-2030)
  • Table 109. Bilirubin Blood Test Bench-top , by Region USD Million (2025-2030)
  • Table 110. Bilirubin Blood Test: by Application(USD Million)
  • Table 111. Bilirubin Blood Test Disease Diagnose , by Region USD Million (2025-2030)
  • Table 112. Bilirubin Blood Test Blood Routine Analysis , by Region USD Million (2025-2030)
  • Table 113. Bilirubin Blood Test Disease Prevention , by Region USD Million (2025-2030)
  • Table 114. Bilirubin Blood Test Others , by Region USD Million (2025-2030)
  • Table 115. Bilirubin Blood Test: by End Use(USD Million)
  • Table 116. Bilirubin Blood Test Hospital , by Region USD Million (2025-2030)
  • Table 117. Bilirubin Blood Test Clinic , by Region USD Million (2025-2030)
  • Table 118. Bilirubin Blood Test Healthcare Institutes , by Region USD Million (2025-2030)
  • Table 119. Bilirubin Blood Test Other , by Region USD Million (2025-2030)
  • Table 120. South America Bilirubin Blood Test, by Country USD Million (2025-2030)
  • Table 121. South America Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 122. South America Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 123. South America Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 124. Brazil Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 125. Brazil Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 126. Brazil Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 127. Argentina Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 128. Argentina Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 129. Argentina Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 130. Rest of South America Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 131. Rest of South America Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 132. Rest of South America Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 133. Asia Pacific Bilirubin Blood Test, by Country USD Million (2025-2030)
  • Table 134. Asia Pacific Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 135. Asia Pacific Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 136. Asia Pacific Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 137. China Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 138. China Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 139. China Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 140. Japan Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 141. Japan Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 142. Japan Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 143. India Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 144. India Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 145. India Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 146. South Korea Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 147. South Korea Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 148. South Korea Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 149. Taiwan Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 150. Taiwan Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 151. Taiwan Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 152. Australia Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 153. Australia Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 154. Australia Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 158. Europe Bilirubin Blood Test, by Country USD Million (2025-2030)
  • Table 159. Europe Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 160. Europe Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 161. Europe Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 162. Germany Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 163. Germany Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 164. Germany Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 165. France Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 166. France Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 167. France Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 168. Italy Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 169. Italy Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 170. Italy Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 171. United Kingdom Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 172. United Kingdom Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 173. United Kingdom Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 174. Netherlands Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 175. Netherlands Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 176. Netherlands Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 177. Rest of Europe Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 178. Rest of Europe Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 179. Rest of Europe Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 180. MEA Bilirubin Blood Test, by Country USD Million (2025-2030)
  • Table 181. MEA Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 182. MEA Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 183. MEA Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 184. Middle East Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 185. Middle East Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 186. Middle East Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 187. Africa Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 188. Africa Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 189. Africa Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 190. North America Bilirubin Blood Test, by Country USD Million (2025-2030)
  • Table 191. North America Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 192. North America Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 193. North America Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 194. United States Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 195. United States Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 196. United States Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 197. Canada Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 198. Canada Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 199. Canada Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 200. Mexico Bilirubin Blood Test, by Type USD Million (2025-2030)
  • Table 201. Mexico Bilirubin Blood Test, by Application USD Million (2025-2030)
  • Table 202. Mexico Bilirubin Blood Test, by End Use USD Million (2025-2030)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bilirubin Blood Test: by Type USD Million (2018-2023)
  • Figure 5. Global Bilirubin Blood Test: by Application USD Million (2018-2023)
  • Figure 6. Global Bilirubin Blood Test: by End Use USD Million (2018-2023)
  • Figure 7. South America Bilirubin Blood Test Share (%), by Country
  • Figure 8. Asia Pacific Bilirubin Blood Test Share (%), by Country
  • Figure 9. Europe Bilirubin Blood Test Share (%), by Country
  • Figure 10. MEA Bilirubin Blood Test Share (%), by Country
  • Figure 11. North America Bilirubin Blood Test Share (%), by Country
  • Figure 12. Global Bilirubin Blood Test share by Players 2023 (%)
  • Figure 13. Global Bilirubin Blood Test share by Players (Top 3) 2023(%)
  • Figure 14. Global Bilirubin Blood Test share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 17. Philips (Netherlands) Revenue: by Geography 2023
  • Figure 18. Drägerwerk AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Drägerwerk AG & Co. KGaA (Germany) Revenue: by Geography 2023
  • Figure 20. Konica Minolta (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Konica Minolta (Japan) Revenue: by Geography 2023
  • Figure 22. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 23. Natus Medical Incorporated (United States) Revenue: by Geography 2023
  • Figure 24. APEL Co.,Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 25. APEL Co.,Ltd. (Japan) Revenue: by Geography 2023
  • Figure 26. AMETEK, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. AMETEK, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Mennen Medical Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Mennen Medical Ltd. (United States) Revenue: by Geography 2023
  • Figure 30. Advanced Instruments (United States) Revenue, Net Income and Gross profit
  • Figure 31. Advanced Instruments (United States) Revenue: by Geography 2023
  • Figure 32. GINEVRI srl (Italy) Revenue, Net Income and Gross profit
  • Figure 33. GINEVRI srl (Italy) Revenue: by Geography 2023
  • Figure 34. AVI Healthcare Pvt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 35. AVI Healthcare Pvt Ltd (India) Revenue: by Geography 2023
  • Figure 36. Global Bilirubin Blood Test: by Type USD Million (2025-2030)
  • Figure 37. Global Bilirubin Blood Test: by Application USD Million (2025-2030)
  • Figure 38. Global Bilirubin Blood Test: by End Use USD Million (2025-2030)
  • Figure 39. South America Bilirubin Blood Test Share (%), by Country
  • Figure 40. Asia Pacific Bilirubin Blood Test Share (%), by Country
  • Figure 41. Europe Bilirubin Blood Test Share (%), by Country
  • Figure 42. MEA Bilirubin Blood Test Share (%), by Country
  • Figure 43. North America Bilirubin Blood Test Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Philips (Netherlands)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Konica Minolta (Japan)
  • Natus Medical Incorporated (United States)
  • APEL Co.,Ltd. (Japan)
  • AMETEK, Inc. (United States)
  • Mennen Medical Ltd. (United States)
  • Advanced Instruments (United States)
  • GINEVRI srl (Italy)
  • AVI Healthcare Pvt Ltd (India)
Additional players considered in the study are as follows:
Beijing M&B (China) , Kejian Hi-tech (China) , Micro Lab (India)
Select User Access Type

Key Highlights of Report


Apr 2024 152 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bilirubin Blood Test Market Quantitative research analysis
Global Bilirubin Blood Test Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Philips (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Konica Minolta (Japan), Natus Medical Incorporated (United States), APEL Co.,Ltd. (Japan), AMETEK, Inc. (United States), Mennen Medical Ltd. (United States), Advanced Instruments (United States), GINEVRI srl (Italy) and AVI Healthcare Pvt Ltd (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Serum Bilirubin has an Important Role in Multiple Clinical Applications" is seen as one of major influencing trends for Bilirubin Blood Test Market during projected period 2023-2030.
The Bilirubin Blood Test market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Bilirubin Blood Test Market Report?

Have a Query? Click Here

Other Related Reports

Clinical Laboratory Service Comprehensive Study by Application (Hematology, Urinalysis, Microbiology, Immunochemistry, Others), Tests (Blood Testing, Urine Testing, Oral Fluid Testing, Hair Testing, ...
$ 3450
Healthcare Claim Management Comprehensive Study by Type (Integrated Solutions, Standalone Solutions), Deployment Mode (Cloud-Based, On-Premise), Components (Software, Hardware, Services) Players and ...
$ 3500
Scoliosis Treatment Comprehensive Study by Type (Structural Scoliosis, Non-Structural Scoliosis), Treatment (Device, Surgery, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Hereditary Cancer Testing Comprehensive Study by Type (Biopsy, Imaging, Others), Application (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Others), End User (Diagnostic Laboratory, Hospitals, Ot...
$ 3500
Veterinary Healthcare Product Comprehensive Study by Type (Therapeutics {Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives & Other Therapeutics}, Diagnostics {Immunodiagnostic Tests, M...
$ 3750
Pet Dental Care Kit Comprehensive Study by Type (Dental Chew, Toothpaste, Toothbrush, Mouthwash, Additives), Animal (Dogs, Cats, Others), Distribution Channels (Online Retail, Offline Retail), End Us...
$ 3350